Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04211194 · ClinicalTrials.gov registry record
Registry for Upper Gastrointestinal Bleeding
A clinical trial of Peptic Ulcer Hemorrhage and Peptic Ulcer, Acute With Hemorrhage, sponsored by AdventHealth.
- Completed
- Registry status
- 2,999
- Enrollment target
- 1
- Study location
NCT04211194: Completed study of Peptic Ulcer Hemorrhage and Peptic Ulcer, Acute With Hemorrhage, sponsored by AdventHealth.
NCT04211194 is a study of Peptic Ulcer Hemorrhage and Peptic Ulcer, Acute With Hemorrhage that has completed, run by AdventHealth. The registered enrollment target is 2,999 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04211194, a study of Peptic Ulcer Hemorrhage and Peptic Ulcer, Acute With Hemorrhage, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- 2,999 participants
- Enrollment target
- 1
- Study location
Study Summary
This project aims to evaluate the data on all patients undergoing endoscopic therapy for upper gastrointestinal bleeding.
Primary Outcome
Mortality rate from upper gastrointestinal bleeding and from any etiology
Conditions Studied
Interventions
- PROCEDURE Upper GI Endoscopy
Study Locations (1)
Florida
- Center for Interventional Endoscopy - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,999 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2021-01-31 |
What the finished NCT04211194 record still lists
NCT04211194 is an observational study that tracks outcomes without assigning an intervention. Its 2,999 participants enrollment target places it among the larger protocols in the corpus.
The record links to 2 conditions, with Peptic Ulcer Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Upper GI Endoscopy is the first listed.
NCT04211194 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04211194 about?
NCT04211194 is a clinical study titled "Registry for Upper Gastrointestinal Bleeding". This project aims to evaluate the data on all patients undergoing endoscopic therapy for upper gastrointestinal bleeding.
What is the current status of trial NCT04211194?
This trial is currently completed. The enrollment target is 2,999 participants. The study started on 2019-10-01. Estimated completion is 2021-01-31.
What conditions does trial NCT04211194 study?
This clinical trial studies the following conditions: Peptic Ulcer Hemorrhage, Peptic Ulcer, Acute With Hemorrhage.
What interventions are being tested in trial NCT04211194?
The interventions under investigation include: Upper GI Endoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT04211194?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04211194 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peptic Ulcer Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI